{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:41:58Z","timestamp":1790872918929,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Neurofilament light chain protein (NfL) is a fluid biomarker of neural injury measurable in cerebrospinal fluid and blood. Patients with different neurodegenerative disorders and mild traumatic brain injury display elevated levels of NfL. However, so far, elevated levels of NfL have not been demonstrated in persons with psychiatric disorders. To our knowledge, the occurrence of NfL in the blood has not previously been studied in persons undergoing forensic psychiatric assessment or persons treated in forensic mental health services. Supposedly, these persons suffer from experiences and conditions with a higher risk of neural injury than other psychiatric patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this pilot study, we investigated plasma levels of NfL in 20 persons undergoing forensic psychiatric assessment and 20 patients at a forensic psychiatric hospital. NfL values were compared with control groups of healthy individuals matched for age and sex.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of increased NfL in both forensic groups was low and did not differ compared with the controls. However, some persons undergoing forensic psychiatric assessment showed slightly elevated values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The slightly elevated values were observed in the group investigated closer in time to the index crime, when elevated NfL levels could be expected to be more prevalent due to acute conditions from the time of the offense. This gives reason to look further into this group.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1176266","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:14:27Z","timestamp":1683173667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study"],"prefix":"10.3389","volume":"14","author":[{"given":"Anja","family":"Fernqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Howner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fpsyt.2019.00840","article-title":"Focus on brain health to improve care, treatment and rehabilitation in forensic psychiatry","volume":"10","author":"Andin\u00e9","year":"2019","journal-title":"Front Psych"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12888-019-2018-6","article-title":"A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder","volume":"19","author":"O\u2019Reilly","year":"2019","journal-title":"BMC Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fpsyt.2019.00279","article-title":"Attention problems predict risk of violence and rehabilitative engagement in mentally disordered offenders","volume":"10","author":"Puzzo","year":"2019","journal-title":"Front Psych"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41386-022-01426-x","article-title":"Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes","volume":"48","author":"Howes","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","article-title":"Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations","volume":"21","author":"McCleery","year":"2019","journal-title":"Dialogues Clin Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fpsyt.2018.00333","article-title":"Imaging violence in schizophrenia: a systematic review and critical discussion of the MRI literature","volume":"9","author":"Fjellvang","year":"2018","journal-title":"Front Psych"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fpsyt.2019.00667","article-title":"Brain structure alterations in poly-drug use: reduced cortical thickness and white matter impairments in regions associated with affective, cognitive, and motor functions","volume":"10","author":"Unterrainer","year":"2019","journal-title":"Front Psych"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e1001150","DOI":"10.1371\/journal.pmed.1001150","article-title":"Risk of violent crime in individuals with epilepsy and traumatic brain injury: a 35-year Swedish population study","volume":"8","author":"Fazel","year":"2011","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1080\/02699050701785054","article-title":"Brain injury in a forensic psychiatry population","volume":"21","author":"Colantonio","year":"2007","journal-title":"Brain Inj"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"507196","DOI":"10.3389\/fpsyt.2020.507196","article-title":"Exploring traumatic brain injuries and aggressive antisocial behaviors in Young male violent offenders","volume":"11","author":"Katzin","year":"2020","journal-title":"Front Psych"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/08039488.2014.908949","article-title":"Mortality among forensic psychiatric patients in Finland","volume":"69","author":"Ojansuu","year":"2015","journal-title":"Nord J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.biopsych.2021.10.010","article-title":"Neurochemical markers of traumatic brain injury: relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction","volume":"91","author":"Shahim","year":"2022","journal-title":"Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the Neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"fcac174","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/brain\/awaa018","article-title":"Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders","volume":"143","author":"Ducharme","year":"2020","journal-title":"Brain"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00415-019-09567-8","article-title":"Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders","volume":"267","author":"Katisko","year":"2020","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/00048674211058684","article-title":"Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives","volume":"56","author":"Eratne","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/alz.12549","article-title":"Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings","volume":"18","author":"Eratne","year":"2022","journal-title":"Alzheimers Dement"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"14271","DOI":"10.1038\/s41598-020-71060-4","article-title":"Plasma \u03b2-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia","volume":"10","author":"Rodrigues-Amorim","year":"2020","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jamapsychiatry.2017.2439","article-title":"Evidence-based pragmatic psychiatry-a call to action","volume":"74","author":"Paulus","year":"2017","journal-title":"JAMA Psychiat"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fpsyt.2019.00963","article-title":"Pharmacological treatment in forensic psychiatry-a systematic review","volume":"10","author":"Howner","year":"2019","journal-title":"Front Psych"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijlp.2015.04.009","article-title":"Introducing a standard of legal insanity: the case of Sweden compared to the Netherlands","volume":"40","author":"Radovic","year":"2015","journal-title":"Int J Law Psychiatry"},{"key":"ref26","volume-title":"Diagnostic and statistical manual of mental disorders DSM-5","year":"2013"},{"key":"ref27","volume-title":"International statistical classification of diseases and related health problems","year":"2019"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref30","first-page":"621221","volume-title":"SFS 1962: 700 Brottsbalk","author":"Sveriges regering","year":"1962"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"101715","DOI":"10.1016\/j.ijlp.2021.101715","article-title":"A register-based comparison study of Swedish patients in forensic psychiatric care 2010 and 2018","volume":"77","author":"Degl' Innocenti","year":"2021","journal-title":"Int J Law Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fpsyt.2018.00553","article-title":"Disease severity in treatment resistant schizophrenia patients is mainly affected by negative symptoms, which mediate the effects of cognitive dysfunctions and neurological soft signs","volume":"9","author":"Iasevoli","year":"2018","journal-title":"Front Psych"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S2215-0366(15)00540-4","article-title":"Brain-imaging studies of treatment-resistant schizophrenia: a systematic review","volume":"3","author":"Mouchlianitis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"754969","DOI":"10.3389\/fpsyt.2021.754969","article-title":"Neurofilament light chain is a promising biomarker in alcohol dependence","volume":"12","author":"Li","year":"2021","journal-title":"Front Psych"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/acer.14712","article-title":"Exploring relationships between alcohol consumption, inflammation, and brain structure in a heavy drinking sample","volume":"45","author":"Karoly","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"831901","DOI":"10.3389\/fnbeh.2022.831901","article-title":"Neurofilament light chain as a biomarker for monitoring the efficacy of transcranial magnetic stimulation on alcohol use disorder","volume":"16","author":"Zhang","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/15622975.2021.1907709","article-title":"Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence","volume":"22","author":"Liu","year":"2021","journal-title":"World J Biol Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-023-03327-6","article-title":"A longitudinal investigation of blood neurofilament light chain levels in chronic cocaine users","author":"Bavato","year":"2023","journal-title":"Mol Neurobiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"103191","DOI":"10.1016\/j.nicl.2022.103191","article-title":"White matter alterations in chronic MDMA use: evidence from diffusion tensor imaging and neurofilament light chain blood levels","volume":"36","author":"Zimmermann","year":"2022","journal-title":"Neuroimage Clin"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e13232","DOI":"10.1111\/adb.13232","article-title":"Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal-associated brain damage: a pilot study","volume":"27","author":"Clergue-Duval","year":"2022","journal-title":"Addict Biol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary Psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet","volume":"7","author":"Pollak","year":"2020","journal-title":"Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.schres.2019.11.023","article-title":"Prevalence of N-methyl-d-aspartate receptor antibody (NMDAR-ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study","volume":"222","author":"Kelleher","year":"2020","journal-title":"Schizophr Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/14999013.2021.1952356","article-title":"Predictors of weight gain and metabolic indexes among men admitted to forensic Psychiatric hospital","volume":"21","author":"Hilton","year":"2022","journal-title":"Int J Forensic Ment Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1176266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:14:33Z","timestamp":1683173673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1176266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":45,"alternative-id":["10.3389\/fpsyt.2023.1176266"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1176266","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"article-number":"1176266"}}